Meanwhile, our country has made progress on this research. Better use pneumococcalvaccine to prevent from a series of disease become the key work from now on.
This result could be considered somewhat surprising, according to Siriwardena, as one recent study did suggest a potential protective effect of the pneumococcalvaccine.
What we did for the pneumococcalvaccine was we said we will pay one point five billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price.